使用Physio Flex 瘤整形环进行中膜修复的初始经验
Kosaku Nishigawa1, Shuhei Kawamoto2, Kazuki Morooka2
1Department of Cardiovascular Surgery, IMS Katsushika Heart Center, 3-30-1 Horikiri, Katsushika, Tokyo, 124-0006, Japan. nippie550102@yahoo.co.jp.
General thoracic and cardiovascular surgery
|July 18, 2025
概括
使用Physio Flex Annuloplasty Ring进行中膜修复,有效控制了185名患者的中膜反. 早期的结果令人满意,残留吐率低,功能性额头狭窄症的发生率可接受.
科学领域:
- 心血管外科心血管外科
- 心脏外科手术 心脏外科手术
- 医疗器械 医疗器械
背景情况:
- 副心脏反 (MR) 是一种显著的膜性心脏病.
- 有效的关 (MV) 修复对于改善患者的治疗结果至关重要.
- 结膜整形环通常用于支持MV修复.
研究的目的:
- 通过使用Physio Flex Annuloplasty Ring来评估米特拉修复的早期临床和心声学结果.
- 评估Physio Flex 膜整形环在各种 mitrale 吐病因方面的疗效.
主要方法:
- 185名用Physio Flex Annuloplasty Ring进行MV修复的患者的回顾性分析 (2020年7月 - 2024年10月).
- 患者患有退行性或功能性MR,重度或中度反.
- 手术技术包括人造带重建,叶片切除,折叠塑料和单独的环结合塑料.
主要成果:
- 操作死亡率为2.2%.
- 在97.3%的患者中观察到术后无/微不足道或轻微的MR.
- 观察到左心室尺寸和右心室缩压的显著减少 (P < 0.001).
- 在13名患者中发生了功能性额狭窄.
结论:
- 用Physio Flex Annuloplasty Ring进行中枢门修复证明了有效的MR控制.
- 取得了令人满意的早期临床和心声回声结果.
- 功能性心肌狭窄的发生率是可以接受的.
相关概念视频
01:27Mitral Valve Prolapse I: Introduction
38
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
38
01:22Mitral Valve Prolapse II: Assessment and Management
39
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
39
01:22Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
01:26Mitral Stenosis III: Medical Management
20
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
20
01:20Mitral Regurgitation I: Introduction
53
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
53
01:25Mitral Regurgitation III: Medical Management
27
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
27